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Abstract 
Compelling evidence indicates that hypocretin/orexin signaling regulates arousal, stress and reward-
seeking behaviors. However, most studies on drug reward-related processes have so far described 
the effects of pharmacological blockers disrupting hypocretin/orexin transmission. We report here an 
extensive study on cocaine-related behaviors in hypocretin/orexin-deficient mice (KO) and their 
heterozygous (HET) and wildtype (WT) littermates. We evaluated behavioral sensitization following 
repeated administrations and preference for an environment repeatedly paired with cocaine 
injections (15 mg/kg). Mice were also trained to self-administer cocaine (0.5-1.5 mg/kg/infusion). Our 
observations show that whereas all mice exhibited quite similar responses to acute administration of 
cocaine, only Hcrt KO mice exhibited reduced cocaine-seeking behaviors following a period of 
abstinence or extinction, and reduced cocaine incubation craving. Further, if the present findings 
confirm that Hcrt deficient mice may display a hypoactive phenotype, possibly linked to a reduced 
alertness concomitant to a decreased exploration of their environment, hypocretin/orexin defiency 
did not cause any attentional deficit. We thus report that innate disruption of hypocretin/orexin 
signaling moderately alters cocaine reward but significantly reduces long-term affective dependence 
that may explain the lack of relapse for cocaine seeking seen in Hcrt KO mice. Overall, with blunted 
cocaine intake at the highest concentration and reduced responsiveness to cocaine cues after 
prolonged abstinence, our findings suggest that hypocretin deficient mice may display signs of 
resilience to cocaine addiction. 
Key words: Hypocretin, orexin, motivation, cocaine, saccharine, relapse 
Highlights: 
• Hypocretin deficiency moderately alters cocaine and saccharine reward  
• Disruption of Hcrt signaling does not alter responsiveness to cue, but rather decreases the 
underlying positive affective state that drives motivated behaviors and invigorate the 
organism to overcome efforts required to get access to reward. 
• Hypocretin deficient mice may display signs of resilience to cocaine abuse 
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Introduction 
Disruption of the hypocretin/orexin (Hcrt) transmission has been originally shown to cause 
destabilization of the boundaries between sleep states in dogs (Lin et al., 1999), in mice (Chemelli et 
al., 1999) and in human narcoleptic patients (Nishino et al., 2000). These observations contributed to 
acknowledge that narcolepsy is most likely related to ongoing loss of Hcrt neurons (Sakurai, 2007; 
Sutcliffe and de Lecea, 2002). Converging evidence have also established that the Hcrt system 
controls sleep and wakefulness through multiple interactions with brain structures involved in the 
regulation of stress, reward, and energy homeostasis (Berridge et al., 2010; Tsujino and Sakurai, 
2009). Accordingly, Hcrt is believed to elicit appropriate levels of arousal to engage exploratory and 
goal-oriented behaviors depending on physiological needs, therefore driving motivation for natural 
reward seeking. Increasing evidence also suggests that upon chronic drug intoxication, the Hcrt 
system may serve for triggering drug-oriented behaviors at the expense of former basic need 
priorities (Boutrel et al., 2013). 
Hcrt neurons arise exclusively from the lateral hypothalamus (LH), a brain structure known for 
mediating the integration and processing of basic needs, and project to the entire brain(Baldo et al., 
2003; Peyron et al., 1998). Hcrt neurons receive abundant input from the limbic system and project 
to all the major components of the extended amygdala (Schmitt et al., 2011), a brain region 
considered to connect the basal forebrain to the classical reward systems of the LH via the medial 
forebrain bundle reward system. For the past few years, Hcrt signaling has been shown to be 
critically involved in drug reward seeking behaviors (Bentzley and Aston-Jones, 2015; Borgland et al., 
2006; Boutrel et al., 2005; Espana et al., 2011; Espana et al., 2010; Flores et al., 2013; Harris et al., 
2005; Hollander et al., 2008; Lawrence et al., 2006; Martin-Fardon et al., 2016; Martin-Fardon and 
Weiss, 2014a, b; Matzeu et al., 2016; Narita et al., 2006; Rao et al., 2013; Schmeichel et al., 2017; 
Thompson and Borgland, 2011). Most of these reports mainly characterized the pharmacological 
properties of the Hypocretin receptor 1 (Hcrtr-1) antagonist, SB 334867, and all these studies 
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converged toward a role of Hcrtr-1 signaling in cocaine reinforcing properties, but one (Riday et al., 
2012). Meanwhile, two remarkable studies using Hcrtr-1 (-/-) mice reported a significant reduction of 
cocaine intake and an impaired cue-dependent fear memory formation (Hollander et al., 2012; Soya 
et al., 2013), and the implication of hypocretin signaling in the regulation cocaine reinforcing 
properties was recently confirmed using a dual receptor antagonist (Gentile et al., 2017a; Gentile et 
al., 2017b). Overall, these observations support past findings claiming that disruption of Hcrt 
signaling prevented footshock- and cue-induced reinstatement of previously extinguished cocaine 
seeking behaviors (Boutrel et al., 2005; Smith et al., 2009; Wang et al., 2009). Hcrt transmission has 
been suggested to selectively regulate “relapse” like behaviors in abstinent rats, without playing 
critical role in the reinforcing effects of cocaine that maintains ongoing drug-taking behavior.  
The commonly used Hcrtr-1 antagonist SB 334867 presents low affinity for 5-HT2B and 5-HT2C 
receptors (Duxon et al., 2001), but most importantly administration of SB 334867 induces sedative 
effects at the highest doses (Rodgers et al., 2001), further questioning the pharmacological 
approaches using this compound (McElhinny et al., 2012). Meanwhile, only a few studies have 
reported drug-seeking behaviors in hypocretin-deficient (Hcrt KO) mice, the original mouse model 
described by Chemelli and colleagues in 1999 that has its own limits as well given the compensatory 
mechanisms most likely occurring during in utero development in absence of Hcrt peptides. To date, 
it has been shown that Hcrt KO mice display diminished signs of precipitated opiate withdrawal 
(Georgescu et al., 2003) and that they do not exhibit morphine-induced place preference (Narita et 
al., 2006), although this latter observation was not replicated recently (Sharf et al., 2010).  Therefore, 
our aim was to extensively investigate cocaine related behaviors in Hcrt-deficient mice (KO), their 
heterozygous (HET) and wild type (WT) male and female littermates. Our results demonstrate that 
innate loss of hypocretin transmission does not impair the acute reinforcing properties of cocaine. 
However, with a blunted cocaine intake at the highest concentration and reduced cocaine-seeking 
behaviors after periods of abstinence, hypocretin deficient mice most likely display signs of resilience 
to cocaine addiction. 
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Materials and methods 
Animals 
We obtained hypocretin/orexin knockout mice (Chemelli et al., 1999) from Prof. M. Yanagisawa 
(HHMI, University of Texas Southwestern Medical Center, Dallas, USA). These mice have been 
backcrossed with C57BL/6J mice (Janvier Labs, Le Genest Saint Isle, France) for 10 generations. Our 
breeding pairs were maintained as heterozygous and crossed to obtain homozygous knockout (KO) 
mice, heterozygous (HET) and wildtype (WT) littermates. For genotype identification, genomic DNA 
extracted from ear biopsy was amplified using PCR amplification with a neomycine primer 5’-CCG 
CTA TCA GGA CAT AGC GTT GGC-3’, or a genomic primer 5’-GAC GAC GGC CTC AGA CTT CTT GGG-3’, 
and genomic primer 3’-TCA CCC CCT TGG GAT AGC CCT TCC-5’ shared by KO and WT mice (Mochizuki 
et al., 2004). 
Mice used in this study were 10-18-weeks old, they were housed in a controlled environment (21 ± 
1°C, humidity 50 ± 10%) and were kept under a reversed 12h light/dark cycle (lights off at 10 am). All 
experiments were performed in accordance with the Swiss Federal Act on Animal Protection and the 
Swiss Animal Ordinance and were approved by the cantonal veterinary office (authorization 1903 to 
B.B.). 
Locomotor sensitization in open fields 
Behavioral tests were performed during the dark cycle. Mice were habituated for 15-min in a large 
circular open field (diameter = 72.5 cm) before each 60-min testing session. Mice were tested for 7 
consecutive days during which all animals were challenged with intraperitoneal (ip) injections of 
saline on day 1 and either with cocaine 15 mg/kg or with saline from day 2 to day 7. Locomotor 
activity was assessed with Ethovision 3.0 software (Noldus®, Wageningen, The Netherlands). To 
further compare the distance travelled by mice 15 min prior and 15 min after injections, a 
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normalization of the data was performed according to the following formula: (distance post injection 
minus distance prior injection)/(distance post injection plus distance prior injection). Negative values 
mean a decrease in the distance traveled during the first 15 min post injection compared to the 15 
min prior injection. Positive values indicate an increase in the distance traveled during the first 15 
min post injection compared to the 15min prior injection. 
Conditioned Place Preference 
Behavioral tests were performed during the dark cycle. The paradigm consisted of a Y-shape box with 
two-equal sized compartments (15 x 15 x 15 cm) separated by a neutral triangular space. The two 
compartments had different visual (dots vs stripes) and tactile (metal grid floor vs spotted floor) 
cues. During habituation (preconditioning phase), all animals were allowed to freely explore both 
compartments for 20 min, and the time spent in each compartment was monitored with a video 
camera and analyzed simultaneously with the software Ethovision 3.0 (Noldus®, Wageningen, The 
Netherlands). Animals displaying >70% of the total time in one compartment were excluded. The 
conditioning phase was performed for 4 consecutive days, with two daily sessions. In the morning, 
animals were injected either with cocaine (15mg/kg ip) or saline and were confined to one 
compartment (randomly assigned at the beginning of the experiment) for a 20-min session. In the 
late afternoon, all animals were treated with saline and were confined in the other compartment for 
another 20-min session. During the test session, all animals were replaced in the CPP apparatus 
without injection, and the time spent exploring both compartment was measured. Mice were 
returned to the CPP apparatus for 20 min after a 2-week period of abstinence during which they 
remained in their home cages. 
Saccharine self-administration acquisition, extinction and reinstatement 
The experiments were conducted in mouse operant chambers (Med Associates, St Albans, VT, USA). 
Mice were trained to self-administer saccharine 0.2% liquid reward on a fixed ratio 1, time out 3 sec 
(FR1 TO3) schedule of reinforcement in the presence of an olfactory cue (apple aroma, Givaudan, 
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Dübendorf, Switzerland) during 30-min daily sessions. A single nose entry in the active nosepoke 
activated a liquid dipper equipped with a 0.01 ml cup and a light cue located inside the nosepoke. 
The liquid reward remained available for 3 sec once access to the liquid dipper had been detected 
with head entry detectors. Supplementary entries in the active nosepoke in the absence of head 
entry detection above the liquid dipper and entries in the inactive nosepoke were recorded but had 
no further consequence. After completion of the training phase, mice were trained to self-administer 
saccharine using a progressive-ratio schedule of reinforcement, which consisted of a systematic 
within-session increase in the ratio of responses required to earn one saccharine reward. Under this 
schedule, mice were required to progressively increase the number of active nosepokes between 
two successive rewards based on the progression sequence given by: response ratio (rounded to 
nearest integer) = (5e(reward× 0.2)) − 5(Richardson and Roberts, 1996). Hence, the progressive-ratio 
schedule followed the progression: 1, 2, 4, 6, 9, 12, 15, 20, 25, 32, 40, 50, 62, 77, 95, 118, 145, 178, 
219, etc. Mice were tested first under food restriction (they were maintained at 85% of their original 
weight), and tested again after 24h access to food ad libitum in their home cages. 
Mice were then returned to the FR1 schedule of reinforcement for at least three successive days 
until stable levels of intake (≤ 25% variation of the mean responses for three consecutive sessions). 
Afterwards, mice underwent an extinction phase until completion of an extinction criterion (<30% of 
the mean responses obtained during the 3 days achieving the stabilization criteria across 3 
consecutive extinction sessions). Animals were then tested for reinstatement of their nosepoking 
activities upon presentation of the olfactory and light cues, and the numbers of entries in the active 
and inactive nosepokes were recorded during 30-min sessions while no liquid reward was delivered. 
For assessing the visual discrimination capacity, WT and KO mice were trained to respond to a cue-
light inside the nosepoke to earn a 0.01ml of saccharine reward. A constant cue-light was randomly 
presented in one of the two nosepokes surrounding the dipper. After stable saccharine self-
administration was achieved, the time presentation of the cue light was restricted to 1 sec, and 
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ultimately 0.5 sec. A single nose entry in the briefly illuminated nosepoke activated a liquid dipper 
equipped with a 0.01 ml of saccharine. The liquid reward remained available for 3 sec once access to 
the liquid dipper had been detected with head entry detectors. Supplementary entries in the active 
nosepoke in the absence of head entry detection above the liquid dipper were recorded as correct 
perseverative responses but had no further consequence. Supplementary entries in the non-
illuminated nosepoke in the absence of head entry detection above the liquid dipper were recorded 
as incorrect perseverative responses. Access to saccharine reward (detected with head entry 
detectors) triggered the start of a 5-sec inter-trial-interval, before brief random illumination of one of 
the two nosepokes. Any nosepoke activity during these 5 sec was recorded as a premature response. 
Jugular vein catheterization 
An indwelling catheter was implanted into the right external jugular vein under oxygen/isoflurane 
vapor anesthesia (Thomsen and Caine, 2007). Briefly, a 7 cm length of silastic tubing (0.3 mm inner 
diameter, 0.6 mm outer diameter, Silastic, Dow Corning Corporation, Midland, MI, USA) was fitted to 
a 22-gauge steel cannula (PlasticsOne, Roanoke, VA, USA) that was bent at a right angle and then 
embedded in a cement disk (Dentalon Plus, Heraeus Kulzer, Germany) with an underlying nylon 
mesh. The catheter tubing was inserted 1.2 cm into the right jugular vein and delicately anchored to 
the vein. The catheter ran subcutaneously to the base located above the midscapular region. All 
incisions were sutured and coated with antibiotic ointment (Bepanthen® Plus, Bayer AG, Zurich, 
Switzerland). After surgery, mice were allowed 4-5 days to recover prior to initiation of self-
administration sessions, during which 0.05 ml of 0.9% saline containing heparin (30 USP units/ml) 
was infused daily through the catheter to forestall clotting. Catheter patency was confirmed after 
completion of the experiment by the infusion of 0.02 to 0.03 ml of Etomidat-®Lipuro (B. Braun, 
Melsungen, Switzerland). Loss of muscle tone and clear signs of anesthesia within 2 sec of infusion 
indicated catheter patency. Only mice with a patent catheter were included in the final results. 
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Cocaine self-administration, extinction and reinstatement 
The experiments were conducted in mouse operant chambers (Med Associates, St Albans, VT, USA), 
either using lever press in the de Lecea Lab (Suppl. Figure 2) or using nose pokes in the Boutrel lab 
(for all other recordings). Mice were trained to self-administer intravenous cocaine (obtained from 
Hänseler AG, Herisau, Switzerland) in the presence of an olfactory cue (apple aroma, Givaudan, 
Dübendorf, Switzerland) under a fixed ratio 1, timeout 20-s (FR1 TO20-s) schedule of reinforcement 
during daily 2-h sessions 7 days per week. A single nose entry in the active nose poke was paired with 
the illumination of a light cue located inside the nosepoke and the delivery of the reinforcer (1 
mg/kg/infusion, 0.015 ml over 1 sec) through the tubing into the intravenous catheter by a Razel 
syringe pump. Entries in the active nosepoke during the TO period and entries in the inactive 
nosepoke were recorded but had no consequence. After mice established stable responding (see 
above) for the training dose (1mg/kg/infusion), the unit dose available for self-administration was 
varied to generate a dose-response function. Escalating doses of cocaine (0.5, 0.75, 1 and 1.5 
mg/kg/infusion) were tested using a Latin-square design such that most of the mice received each 
dose. Each dose exposure was repeated twice, and the mean responses for each animal were 
calculated. Mice with a patent catheter were returned to the training dose for at least three 
successive days until stable levels of intake. Mice then underwent 2-h extinction sessions with saline 
infusion in absence of both the olfactory cue and the illuminated nosepoke until reaching the 
extinction criterion. The criterion was achieved when responses on the active hole were <30% of the 
mean responses obtained during the 3 days achieving the acquisition criteria across 3 consecutive 
extinction sessions. Tests for reinstatement were conducted under the same conditions used in the 
cocaine self-administration phase (olfactory cue and illuminated nosepoke) but saline replaced 
cocaine. 
For assessing the expression of cocaine incubation craving, another group of WT and KO mice was 
trained for self-administering cocaine (1mg/kg/infusion) in similar conditions but each cocaine 
infusion was paired with three home cage flashlights. After stable cocaine self-administration was 
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achieved, mice were returned to the operant chambers to assess contextual cue-induced cocaine 
seeking after 1, 7, 14, 21 and 28 days of withdrawal. On each test day, mice were replaced into the 
same self-administration chambers, and cocaine cue-induced drug-seeking behavior was assessed 
under the same previously described conditions but cocaine was unavailable. Each session lasted 2 
hours, as well. 
Data analysis 
Data shown are presented as the mean ± SEM. We first assessed the model assumptions for ANOVA 
(normality assessed with a Shapiro-Wilk test, and homogeneity of variances assessed with a Bartlett’s 
test). Then data were subjected to one- and two-factor repeated measures analysis of variance 
(ANOVA) followed by Tukey’s HSD post-hoc tests. Statistical analyses were performed using R 
software (version 2.15.1), and the level of significance was set at 0.05. (See supplementary 
information for extended analysis). 
 
Results 
Loss of Hcrt transmission only delays cocaine-induced behavioral sensitization  
First exposure to cocaine treatment induced a significant increase in locomotor activity in WT and 
HET males, and to a much lesser extent in KO ones (Figure 1A), whereas the locomotor activity of 
mice treated with saline remained unchanged. WT, HET and KO mice were further challenged with 
15mg/kg of cocaine for six more days in order to monitor the development and acquisition of cocaine 
sensitization. In contrast to the saline group, all mice exhibited a robust sensitization with chronic 
cocaine administration (WT, F(1,110)=121.4, p-value<0.001; HET, F(1,117)=69.0, p-value<0.001; KO, 
F(1,117)=116.6, p-value<0.001) but KO males displayed delayed behavioral sensitization compared to 
WTs (F(2,308)=36.7, p<0.001; Figure 1B). On day 7, all males exhibited similar locomotor activity (WT: 
58389 ± 7359 cm, HET: 45834 ± 5483 cm and KO: 42303 ± 6106 cm, post-hoc test: p-value>0.05). 
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Noteworthy, we found that KO mice treated with saline tend to display a reduced locomotor activity 
compared to WT and HET animals, confirming previous reports(Hara et al., 2001; Mochizuki et al., 
2004). We decided to compare the activity of cocaine- and saline-treated mice during the 15 min 
before drug injection and the 15 min after the injection in order to evaluate the amplitude of 
individual behavioral sensitizations. Saline-treated mice displayed negative amplitudes reflecting a 
decreased locomotor activity after the injection. In contrast, mice of the three genotypes exhibited 
positive behavioral sensitization amplitudes starting from day 2 (first cocaine administration) 
reflecting the increased locomotor activity after cocaine injection. Interestingly, WT, HET and KO 
mice displayed similar amplitude of behavioral sensitization, except on the first day of cocaine 
treatment during which KO mice responses remained significantly lowered (F(2,308) (genotypes)=7.0, 
p<0.01; Figure 1C). Thus, cocaine-induced behavioral sensitization was delayed in KO mice, but when 
comparing the amplitude of the sensitization using each mouse as its own control, we conclude that 
all mice responded likewise to chronic cocaine administration.  
Unexpectedly, females of the three genotypes did exhibit identical responses to repeated cocaine 
injections in contrast to male mice (F(2,560) (sex x genotype)=9.88, p<0.001; Figure 1D-F). Considering 
that females might have been more sensitive than males to the anxiogenic environment of the open 
field (Bangasser et al., 2010), which could have explained the enhanced response to chronic cocaine 
administrations, we assessed cocaine-induced behavioral sensitization in individual cages equipped 
with running wheels (Suppl. Figure 1). Statistical analyses (see supplementary information) revealed 
a significant reduction in the total distance traveled by KO females at baseline (prior injection) 
compared to the performance displayed by HET and WT mice, but ultimately, WT, HET and KO 
females did exhibit similar amplitude of the cocaine-induced behavioral sensitization, which agrees 
with the data reported above. 
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Hcrt deficient mice display a robust cocaine-induced place preference  
We tested then the rewarding effects of cocaine (15 mg/kg) on WT, HET and KO males and females 
using a conditioned place preference (CPP) paradigm. The CPP procedure was conducted in four 
phases: habituation (pretest), conditioning, test session (1st posttest) and a second posttest session 
after 2-weeks of abstinence (meaning two weeks after the last cocaine administration). All animals 
(males and females of the three genotypes) exhibited a marked preference for the compartment 
previously paired with cocaine administration on the 1st posttest session compared to the pretest, 
whereas saline treated animals did not prefer one compartment over the other 
[F(1,186)(treatment)=39.2, p<0.001; F(1,186)(session)=76.1, p<0.001; F(1,186)(treatment x session)=61.5, 
p<0.001; Figure 2A and 2B]. Further, the rewarding effect of cocaine was independent of the genetic 
background (F(2,186)=0.3, p>0.05) and the sex (F(1,186)=1.4, p>0.05). After a two week-period of 
abstinence, all mice were returned to the CPP apparatus. WT and HET mice maintained their 
preference for the compartment previously paired with cocaine administrations whereas KO male 
and female mice stopped expressing such a preference [F(2,174)(genotype x session)=0.02, p<0.05; 
Figure 2C and 2D]. 
The distance travelled by mice during the 20 min of the pretest and the posttest sessions were also 
monitored. In agreement with the behavioral sensitization data, only WT and HET animals exhibited 
an increased locomotor activity during the posttest session (F(1,186)=34.6, p<0.001; Suppl. Figure 2A 
and 2B), although mice did not receive any cocaine injection on the test day (see supplementary 
information). Two weeks after the last cocaine injection, although WT and HET males and females 
persisted in preferring the former cocaine-paired compartment, all mice exhibited similar locomotor 
activity (Suppl. Figure 2C and 2D). 
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Hypocretin deficient mice manifest a blunted cocaine intake at the highest dose and a reduced cue-
induced reinstatement of previously extinguished cocaine seeking behavior 
After showing that WT, HET and KO mice exhibited similar preference for the rewarding properties of 
cocaine, we assessed cocaine self-administration in WT and KO males only. In a first series of 
experiments, WT and KO mice were trained to lever press for intravenously self-administering 
cocaine (0.7 mg/kg/infusion). We did not observe any difference either in a fixed- or a progressive- 
ratio schedule of reinforcement (Suppl. Figure 3). In a second series of tests, mice were trained to 
nose poke for self-administering cocaine (0.5-1.5 mg/kg/infusion). A two-factor ANOVA revealed 
significant main effects for cocaine dose (F(3,235)=13.3, p<0.001) and genotype (F(1,235)=10.3, p<0.01), 
with a significant dose x genotype interaction (F(3,235)=2.75, p<0.05). Hence, although Hcrt deficient 
mice self-administered middle range doses of cocaine (0.5-1 mg/kg/infusion) reflecting a normal 
ability to acquire ongoing cocaine-taking behaviors compared to WT littermates, a Tukey’s HSD post-
hoc tests among means revealed that KO mice displayed a blunted cocaine intake at the highest dose 
(1.5 mg/kg/infusion) compared to their WT littermates (Figure 3A).   
After a period of extinction (10.4 r 0.9 versus 10.2 r 0.5 sessions in WT and KO mice, respectively) 
during which mice gradually decreased their nosepoking behavior in absence of light and olfactory 
cues, we assessed the ability of these mice to reinstate their cocaine seeking behavior upon 
presentation of the light and olfactory cues. A two-way repeated measure ANOVA revealed 
significant main effects for genotype (F(1,114)=17.24, p<0.001), phase (F(2,114)=58.36, p<0.001) and 
genotype x phase (F(2,114)=4.99, p<0.01). Tukey’s HSD post-hoc tests revealed that WT mice 
significantly reinstated their previously extinguished cocaine-seeking behaviors whereas KO mice did 
not (Figure 3B). To assess whether Hcrt deficient mice may display signs of resilience to the long-term 
reinforcing properties of cocaine, we ran a cocaine incubation craving procedure in which mice were 
returned to the operant chambers every week under identical conditions (see materials and 
methods, and supplementary information). A two-way repeated measure ANOVA revealed significant 
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main effects for genotype (F(1,95)=5.79, p<0.05) and session (F(5,95)=12.97 p<0.001) and a significant 
genotype x session interaction (F(5,95)=2.63, p<0.05). Tukey’s HSD post-hoc tests revealed that 
whereas WT mice exhibited a significant increase in cocaine seeking behavior at Day 7, 14 and 21, KO 
mice showed a significant but blunted cocaine incubation craving after a 2-week period of 
withdrawal (Figure 3C). 
It then appeared relevant to assess the acquisition, extinction and reinstatement of saccharine 
seeking behaviors in WT and KO mice since the Hcrt was shown to play a key role in the reinforcing 
properties of sweetened taste (Cason and Aston-Jones, 2013a, b; Ho and Berridge, 2013). We first 
trained another group of mice to self-administer saccharine 0.2% per os during the light and the dark 
phases since a recent report claimed that Hcrt deficient mice displayed reduced motivation for food 
reward specifically during the light period (McGregor et al., 2011). In our hands, food restricted Hcrt 
deficient mice exhibited a significantly reduced motivation (see Suppl. Information for statistical 
analyses) for saccharine reward in a progressive ratio schedule of reinforcement during both the light 
and dark period compared to WT mice (Suppl. Figure 4). Interestingly, when fed ad libitum, WT mice 
drastically reduced the amount of work required to earn liquid rewards whereas KO mice did not, 
confirming that Hcrt deficient mice could not provide supplementary effort despite starvation 
(Yamanaka et al., 2003). Another group of WT and KO mice (fed ad libitum) was then trained for self-
administering saccharine in a fixed ratio 1 schedule until stable intake, and after a period of 
extinction, we assessed their ability to reinstate their saccharine seeking behavior upon presentation 
of the light and olfactory cues. Again, a two-way repeated measure ANOVA revealed significant main 
effects for genotype (F(1,127)=45.68, p<0.001), phase (F(2,127)=152.12, p<0.001) and genotype x phase 
(F(2,127)=13.22, p<0.01). Post-hoc tests revealed that only WT mice significantly reinstated their 
previously extinguished saccharine-seeking behavior (Figure 4A), confirming KO mice deficits to 
reinstate reward seeking after a period of extinction. Since the absence of cue-induced 
reinstatement could have been explained by altered responsiveness to cue rather than alterations in 
underlying motivational states, we performed a visual discrimination task in WT and KO mice to 
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assess any putative attention deficits in Hcrt deficient mice. Both groups of mice were trained to 
respond to a briefly illuminated cue light (0.5 sec) inside the nosepokes to earn a 0.01ml of 
saccharine reward. This cue light was randomly presented between the two nosepokes. Whereas 
Hcrt deficient mice failed to reinstate a previously extinguished saccharine seeking behavior, their 
visual discrimination capacity was similar to that of WT mice (Figure 4B), further suggesting that 
disruption of Hcrt signaling does not alter responsiveness to cue, but rather decreases the underlying 
positive affective state that drives motivated behaviors.  
 
Discussion 
In the present work, we observed that WT, HET and KO males exhibited cocaine-induced locomotor 
sensitization in an open field. However, KO males showed a delayed and attenuated cocaine-induced 
behavioral sensitization compared to WT mice, which is in agreement with previous observations 
using the Hcrtr-1 antagonist SB-334867 in rodents (Borgland et al., 2006; Hutcheson et al., 2011; 
Quarta et al., 2010). Nonetheless, a comparison of the distance traveled during the first 15 min 
following cocaine treatment with the distance traveled during the 15 min of habituation shows that 
the differences between KO, HET and WT are largely reduced. Indeed, males of the three genotypes 
exhibited similar amplitude in behavioral sensitization following daily cocaine treatment, with the 
notable exception of the first cocaine session during which KO males displayed a reduced cocaine-
induced hyperlocomotion. Unexpectedly, female mice of the three genotypes exhibited similar 
cocaine-induced behavioral sensitization. Could higher levels of leptin, as previously reported in 
female Hcrt KO mice (Fujiki et al., 2006), compensate for Hcrt deficiency and thus facilitate cocaine-
induced behavioral sensitization (Fulton et al., 2006; Fulton et al., 2000) remains an open question 
that needs further investigation to be addressed. With the highest expression of Hcrtr-1 in the brain 
being the locus coeruleus (LC) (Hervieu et al., 2001), another plausible explanation would take into 
account the sexual dimorphism in LC dendritic morphology (Bangasser et al., 2011) to explain the 
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delayed behavioral sensitization in KO males. Indeed, an increased attenuation of basal and cocaine-
induced locomotor activities were already reported after administration of SB 334867 in males 
compared to female rats (Zhou et al., 2012).  
Interestingly, despite a reduced locomotor activity compared to WT and HET littermates in a cocaine-
induced place preference paradigm, KO animals did exhibit a significant preference for the context 
previously paired with repeated drug injections, in line with a previous report (Sharf et al., 2010). 
Though, Hcrt KO mice have been shown to display disrupted dopamine signaling and attenuated 
dopamine responses to cocaine (Espana et al., 2010; Shaw et al., 2016), which contrasts with our 
findings. However, dopamine is not critical for developing cocaine-induced CPP since dopamine 
deficient mice display normal CPP possibly through serotonin signaling (Hnasko et al., 2007). 
Noteworthy, Hcrt KO mice exhibit reduced dopamine levels and a higher basal serotonin ratio 
relative to WT (Mori et al., 2010), which could explain the acquisition of the cocaine-induced CPP, 
and raises the question of compensatory mechanisms occurring during embryo development in Hcrt 
deficient mice, that most likely would be different from those occurring in Hcrt-1-R KO mice 
(Hollander et al., 2012). Our hypothesis is that the reduced dopamine response to cocaine, reported 
in Hcrt deficient mice by Espana and colleagues (2010), might not have significant consequences on 
the acquisition and expression but on the long-lasting responsiveness to cocaine cues. Indeed, the 
preference for an environment previously paired with cocaine reward has been accounted to persist 
for up to four weeks in rodents (Bardo et al., 1986; Mueller and Stewart, 2000). Here, we report that 
not only KO mice stopped expressing such a preference two weeks after the last cocaine injection, 
but they also exhibited a weakened cocaine incubation craving after a 2-week period of withdrawal, 
in striking contrast to WT animals. Hence, the Hcrt system might play a key role in the long-lasting 
conditioned responses to cocaine.  
In agreement with the above-mentioned observations, we report comparable acquisition of self-
administration behaviors for middle range doses of cocaine in WT and Hcrt deficient mice. However, 
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KO animals consumed significantly less cocaine than WT littermates at the highest dose tested, 1.5 
mg/kg/infusion, suggesting a blunted cocaine intake in these mutants. Interestingly, a significant 
reduction of the motivation for saccharine reward was observed in KO mice compared to WT mice 
under food restriction during both the light and dark phases (Suppl. Figure 3). Further, when sated, 
only WT mice exhibited a significant decrease in the effort required for liquid reward suggesting that 
food restriction did not enhance motivation for saccharine in KO mice, notably during the dark 
period. Our observations contrast with those reported by McGregor and colleagues (2011), but are in 
line with the reduced alertness (Chemelli et al., 1999), the absence of fasting-induced increase in 
arousal and motor activity (Yamanaka et al., 2003), and the reduced sucrose intake reported in Hcrt 
deficient mice (Matsuo et al., 2011). Interestingly, when KO mice were off cocaine (meaning after a 
period of extinction), they displayed a decreased cue-induced reinstatement for reward seeking that 
was similar to the deficit they exhibited when challenged in a cue-induced reinstatement for 
saccharine seeking. These series of observation fit with the motivational activation hypothesis 
suggested by Mahler and colleagues, according to which Hcrt/Ox peptides facilitate reward seeking 
when this seeking is highly motivated by a physiological need and/or by a psychological need 
triggered by external cues or stressors (Mahler et al., 2014).  
Ultimately, with WT and KO mice displaying similar visual discrimination capacities, we hypothesize 
that the constant hypoactive phenotype seen in the KO mice, that most likely is accountable for their 
reduced tendency to explore the environment, is probably due to a reduced motivational drive in 
absence of urge or basic needs. Our findings suggest that although the stimulant effects of cocaine 
compensate their apathy-like behavior, Hcrt deficient mice keep control: they take cocaine when 
available but do not exhibit significant/exaggerated efforts for cocaine seeking during prolonged 
abstinence, therefore displaying signs of reduced vulnerability towards cocaine addiction. 
In sum, our findings provide clear evidence that innate loss of Hcrt peptides most likely does not 
decrease the acute reinforcing properties of cocaine (in contrast to Hcrt-1-R knock out reported by 
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Hollander and colleagues in 2012), but possibly decrease its long-term effects. Interestingly though, 
with a blunted cocaine intake at the highest concentration and reduced reinstatement of cocaine-
seeking behaviors after periods of abstinence (either using an operant conditioning procedure or a 
conditioned place preference paradigm), Hcrt deficient mice seem to display signs of resilience to 
cocaine abuse. Our observations further support the complex role of the Hcrt/Ox signaling in the 
rewarding and motivational properties of drugs of abuse, with a system possibly contributing to 
invigorating the organism to seek for the drug, thus overcoming work and effort to perform to 
ultimately get access to the drug. In line with former observations reported in the literature, our data 
highlight the potential therapeutic utility of disrupting hypocretin/orexin transmission for alleviating 
symptoms of drug dependence, notably by reducing the urge for drug seeking during protracted 
abstinence. 
 
Acknowledgments 
This research was supported by the Swiss National Science Foundation (3100A0-112101 and 31003A-
133056 to B.B).  
The authors report no conflict of interest. 
 
  
Steiner et al. 
 
19 
 
References 
Baldo, B. A., Daniel, R. A., Berridge, C. W., Kelley, A. E., 2003. Overlapping distributions of 
orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions 
mediating arousal, motivation, and stress. J Comp Neurol 464, 220-237. 
Bangasser, D. A., Curtis, A., Reyes, B. A., Bethea, T. T., Parastatidis, I., Ischiropoulos, H., Van 
Bockstaele, E. J., Valentino, R. J., 2010. Sex differences in corticotropin-releasing factor receptor 
signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. 
Mol Psychiatry 15, 877, 896-904. 
Bangasser, D. A., Zhang, X., Garachh, V., Hanhauser, E., Valentino, R. J., 2011. Sexual dimorphism in 
locus coeruleus dendritic morphology: a structural basis for sex differences in emotional arousal. 
Physiol Behav 103, 342-351. 
Bardo, M. T., Neisewander, J. L., Miller, J. S., 1986. Repeated testing attenuates conditioned place 
preference with cocaine. Psychopharmacology (Berl) 89, 239-243. 
Bentzley, B. S., Aston-Jones, G., 2015. Orexin-1 receptor signaling increases motivation for cocaine-
associated cues. Eur J Neurosci 41, 1149-1156. 
Berridge, C. W., Espana, R. A., Vittoz, N. M., 2010. Hypocretin/orexin in arousal and stress. Brain Res 
1314, 91-102. 
Borgland, S. L., Taha, S. A., Sarti, F., Fields, H. L., Bonci, A., 2006. Orexin A in the VTA is critical for the 
induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49, 589-601. 
Boutrel, B., Kenny, P. J., Specio, S. E., Martin-Fardon, R., Markou, A., Koob, G. F., de Lecea, L., 2005. 
Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc 
Natl Acad Sci U S A 102, 19168-19173. 
Boutrel, B., Steiner, N., Halfon, O., 2013. The hypocretins and the reward function: what have we 
learned so far? Front Behav Neurosci 7, 59. 
Cason, A. M., Aston-Jones, G., 2013a. Attenuation of saccharin-seeking in rats by orexin/hypocretin 
receptor 1 antagonist. Psychopharmacology (Berl). 
Cason, A. M., Aston-Jones, G., 2013b. Role of orexin/hypocretin in conditioned sucrose-seeking in 
rats. Psychopharmacology (Berl) 226, 155-165. 
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., 
Williams, S. C., Xiong, Y., Kisanuki, Y., Fitch, T. E., Nakazato, M., Hammer, R. E., Saper, C. B., 
Yanagisawa, M., 1999. Narcolepsy in orexin knockout mice: molecular genetics of sleep 
regulation. Cell 98, 437-451. 
Duxon, M. S., Stretton, J., Starr, K., Jones, D. N., Holland, V., Riley, G., Jerman, J., Brough, S., Smart, D., 
Johns, A., Chan, W., Porter, R. A., Upton, N., 2001. Evidence that orexin-A-evoked grooming in the 
rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement. 
Psychopharmacology (Berl) 153, 203-209. 
Espana, R. A., Melchior, J. R., Roberts, D. C., Jones, S. R., 2011. Hypocretin 1/orexin A in the ventral 
tegmental area enhances dopamine responses to cocaine and promotes cocaine self-
administration. Psychopharmacology (Berl) 214, 415-426. 
Espana, R. A., Oleson, E. B., Locke, J. L., Brookshire, B. R., Roberts, D. C., Jones, S. R., 2010. The 
hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic 
dopamine system. Eur J Neurosci 31, 336-348. 
Flores, A., Maldonado, R., Berrendero, F., 2013. The Hypocretin/Orexin Receptor-1 as a Novel Target 
to Modulate Cannabinoid Reward. Biol Psychiatry. 
Fujiki, N., Yoshida, Y., Zhang, S., Sakurai, T., Yanagisawa, M., Nishino, S., 2006. Sex difference in body 
weight gain and leptin signaling in hypocretin/orexin deficient mouse models. Peptides 27, 2326-
2331. 
Fulton, S., Pissios, P., Manchon, R. P., Stiles, L., Frank, L., Pothos, E. N., Maratos-Flier, E., Flier, J. S., 
2006. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 51, 811-822. 
Steiner et al. 
 
20 
 
Fulton, S., Woodside, B., Shizgal, P., 2000. Modulation of brain reward circuitry by leptin. Science 
287, 125-128. 
Gentile, T. A., Simmons, S. J., Barker, D. J., Shaw, J. K., Espana, R. A., Muschamp, J. W., 2017a. 
Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic 
properties of cocaine. Addict Biol. 
Gentile, T. A., Simmons, S. J., Watson, M. N., Connelly, K. L., Brailoiu, E., Zhang, Y., Muschamp, J. W., 
2017b. Effects of Suvorexant, a Dual Orexin/Hypocretin Receptor Antagonist, on Impulsive 
Behavior Associated with Cocaine. Neuropsychopharmacology. 
Georgescu, D., Zachariou, V., Barrot, M., Mieda, M., Willie, J. T., Eisch, A. J., Yanagisawa, M., Nestler, 
E. J., DiLeone, R. J., 2003. Involvement of the lateral hypothalamic peptide orexin in morphine 
dependence and withdrawal. J Neurosci 23, 3106-3111. 
Hara, J., Beuckmann, C. T., Nambu, T., Willie, J. T., Chemelli, R. M., Sinton, C. M., Sugiyama, F., 
Yagami, K., Goto, K., Yanagisawa, M., Sakurai, T., 2001. Genetic ablation of orexin neurons in mice 
results in narcolepsy, hypophagia, and obesity. Neuron 30, 345-354. 
Harris, G. C., Wimmer, M., Aston-Jones, G., 2005. A role for lateral hypothalamic orexin neurons in 
reward seeking. Nature 437, 556-559. 
Hervieu, G. J., Cluderay, J. E., Harrison, D. C., Roberts, J. C., Leslie, R. A., 2001. Gene expression and 
protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 103, 
777-797. 
Hnasko, T. S., Sotak, B. N., Palmiter, R. D., 2007. Cocaine-conditioned place preference by dopamine-
deficient mice is mediated by serotonin. J Neurosci 27, 12484-12488. 
Ho, C. Y., Berridge, K. C., 2013. An orexin hotspot in ventral pallidum amplifies hedonic 'liking' for 
sweetness. Neuropsychopharmacology 38, 1655-1664. 
Hollander, J. A., Lu, Q., Cameron, M. D., Kamenecka, T. M., Kenny, P. J., 2008. Insular hypocretin 
transmission regulates nicotine reward. Proc Natl Acad Sci U S A 105, 19480-19485. 
Hollander, J. A., Pham, D., Fowler, C. D., Kenny, P. J., 2012. Hypocretin-1 receptors regulate the 
reinforcing and reward-enhancing effects of cocaine: pharmacological and behavioral genetics 
evidence. Front Behav Neurosci 6, 47. 
Hutcheson, D. M., Quarta, D., Halbout, B., Rigal, A., Valerio, E., Heidbreder, C., 2011. Orexin-1 
receptor antagonist SB-334867 reduces the acquisition and expression of cocaine-conditioned 
reinforcement and the expression of amphetamine-conditioned reward. Behav Pharmacol 22, 
173-181. 
Lawrence, A. J., Cowen, M. S., Yang, H. J., Chen, F., Oldfield, B., 2006. The orexin system regulates 
alcohol-seeking in rats. Br J Pharmacol 148, 752-759. 
Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P. J., Nishino, S., Mignot, E., 
1999. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) 
receptor 2 gene. Cell 98, 365-376. 
Mahler, S. V., Moorman, D. E., Smith, R. J., James, M. H., Aston-Jones, G., 2014. Motivational 
activation: a unifying hypothesis of orexin/hypocretin function. Nat Neurosci 17, 1298-1303. 
Martin-Fardon, R., Cauvi, G., Kerr, T. M., Weiss, F., 2016. Differential role of hypothalamic 
orexin/hypocretin neurons in reward seeking motivated by cocaine versus palatable food. Addict 
Biol. 
Martin-Fardon, R., Weiss, F., 2014a. Blockade of hypocretin receptor-1 preferentially prevents 
cocaine seeking: comparison with natural reward seeking. Neuroreport 25, 485-488. 
Martin-Fardon, R., Weiss, F., 2014b. N-(2-methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-yl urea 
(SB334867), a hypocretin receptor-1 antagonist, preferentially prevents ethanol seeking: 
comparison with natural reward seeking. Addict Biol 19, 233-236. 
Matsuo, E., Mochizuki, A., Nakayama, K., Nakamura, S., Yamamoto, T., Shioda, S., Sakurai, T., 
Yanagisawa, M., Shiuchi, T., Minokoshi, Y., Inoue, T., 2011. Decreased intake of sucrose solutions 
in orexin knockout mice. J Mol Neurosci 43, 217-224. 
Steiner et al. 
 
21 
 
Matzeu, A., Kerr, T. M., Weiss, F., Martin-Fardon, R., 2016. Orexin-A/Hypocretin-1 Mediates Cocaine-
Seeking Behavior in the Posterior Paraventricular Nucleus of the Thalamus via Orexin/Hypocretin 
Receptor-2. J Pharmacol Exp Ther 359, 273-279. 
McElhinny, C. J., Jr., Lewin, A. H., Mascarella, S. W., Runyon, S., Brieaddy, L., Carroll, F. I., 2012. 
Hydrolytic instability of the important orexin 1 receptor antagonist SB-334867: possible 
confounding effects on in vivo and in vitro studies. Bioorg Med Chem Lett 22, 6661-6664. 
McGregor, R., Wu, M. F., Barber, G., Ramanathan, L., Siegel, J. M., 2011. Highly Specific Role of 
Hypocretin (Orexin) Neurons: Differential Activation as a Function of Diurnal Phase, Operant 
Reinforcement versus Operant Avoidance and Light Level. J Neurosci 31, 15455-15467. 
Mochizuki, T., Crocker, A., McCormack, S., Yanagisawa, M., Sakurai, T., Scammell, T. E., 2004. 
Behavioral state instability in orexin knock-out mice. J Neurosci 24, 6291-6300. 
Mori, T., Ito, S., Kuwaki, T., Yanagisawa, M., Sakurai, T., Sawaguchi, T., 2010. Monoaminergic 
neuronal changes in orexin deficient mice. Neuropharmacology 58, 826-832. 
Mueller, D., Stewart, J., 2000. Cocaine-induced conditioned place preference: reinstatement by 
priming injections of cocaine after extinction. Behav Brain Res 115, 39-47. 
Narita, M., Nagumo, Y., Hashimoto, S., Khotib, J., Miyatake, M., Sakurai, T., Yanagisawa, M., 
Nakamachi, T., Shioda, S., Suzuki, T., 2006. Direct involvement of orexinergic systems in the 
activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J 
Neurosci 26, 398-405. 
Nishino, S., Ripley, B., Overeem, S., Lammers, G. J., Mignot, E., 2000. Hypocretin (orexin) deficiency in 
human narcolepsy. Lancet 355, 39-40. 
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., Kilduff, T. S., 1998. 
Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18, 9996-
10015. 
Quarta, D., Valerio, E., Hutcheson, D. M., Hedou, G., Heidbreder, C., 2010. The orexin-1 receptor 
antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus 
accumbens and decreases the expression of amphetamine sensitization. Neurochem Int 56, 11-
15. 
Rao, Y., Mineur, Y. S., Gan, G., Wang, A. H., Liu, Z. W., Wu, X., Suyama, S., de Lecea, L., Horvath, T. L., 
Picciotto, M. R., Gao, X. B., 2013. Repeated in vivo exposure of cocaine induces long-lasting 
synaptic plasticity in hypocretin/orexin neurons in the lateral hypothalamus in mice. J Physiol. 
Richardson, N. R., Roberts, D. C., 1996. Progressive ratio schedules in drug self-administration studies 
in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66, 1-11. 
Riday, T. T., Fish, E. W., Robinson, J. E., Jarrett, T. M., McGuigan, M. M., Malanga, C. J., 2012. Orexin-1 
receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice. 
Brain Res 1431, 53-61. 
Rodgers, R. J., Halford, J. C., Nunes de Souza, R. L., Canto de Souza, A. L., Piper, D. C., Arch, J. R., 
Upton, N., Porter, R. A., Johns, A., Blundell, J. E., 2001. SB-334867, a selective orexin-1 receptor 
antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur 
J Neurosci 13, 1444-1452. 
Sakurai, T., 2007. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat 
Rev Neurosci 8, 171-181. 
Schmeichel, B. E., Herman, M. A., Roberto, M., Koob, G. F., 2017. Hypocretin Neurotransmission 
Within the Central Amygdala Mediates Escalated Cocaine Self-administration and Stress-Induced 
Reinstatement in Rats. Biol Psychiatry 81, 606-615. 
Schmitt, O., Usunoff, K. G., Lazarov, N. E., Itzev, D. E., Eipert, P., Rolfs, A., Wree, A., 2011. Orexinergic 
innervation of the extended amygdala and basal ganglia in the rat. Brain Struct Funct. 
Sharf, R., Guarnieri, D. J., Taylor, J. R., DiLeone, R. J., 2010. Orexin mediates morphine place 
preference, but not morphine-induced hyperactivity or sensitization. Brain Res 1317, 24-32. 
Shaw, J. K., Ferris, M. J., Locke, J. L., Brodnik, Z. D., Jones, S. R., Espana, R. A., 2016. Hypocretin/orexin 
knock-out mice display disrupted behavioral and dopamine responses to cocaine. Addict Biol. 
Steiner et al. 
 
22 
 
Smith, R. J., See, R. E., Aston-Jones, G., 2009. Orexin/hypocretin signaling at the orexin 1 receptor 
regulates cue-elicited cocaine-seeking. Eur J Neurosci 30, 493-503. 
Soya, S., Shoji, H., Hasegawa, E., Hondo, M., Miyakawa, T., Yanagisawa, M., Mieda, M., Sakurai, T., 
2013. Orexin receptor-1 in the locus coeruleus plays an important role in cue-dependent fear 
memory consolidation. J Neurosci 33, 14549-14557. 
Sutcliffe, J. G., de Lecea, L., 2002. The hypocretins: setting the arousal threshold. Nat Rev Neurosci 3, 
339-349. 
Thompson, J. L., Borgland, S. L., 2011. A role for hypocretin/orexin in motivation. Behav Brain Res 
217, 446-453. 
Tsujino, N., Sakurai, T., 2009. Orexin/hypocretin: a neuropeptide at the interface of sleep, energy 
homeostasis, and reward system. Pharmacol Rev 61, 162-176. 
Wang, B., You, Z. B., Wise, R. A., 2009. Reinstatement of cocaine seeking by hypocretin (orexin) in the 
ventral tegmental area: independence from the local corticotropin-releasing factor network. Biol 
Psychiatry 65, 857-862. 
Yamanaka, A., Beuckmann, C. T., Willie, J. T., Hara, J., Tsujino, N., Mieda, M., Tominaga, M., Yagami, 
K., Sugiyama, F., Goto, K., Yanagisawa, M., Sakurai, T., 2003. Hypothalamic orexin neurons 
regulate arousal according to energy balance in mice. Neuron 38, 701-713. 
Zhou, L., Ghee, S. M., Chan, C., Lin, L., Cameron, M. D., Kenny, P. J., See, R. E., 2012. Orexin-1 receptor 
mediation of cocaine seeking in male and female rats. J Pharmacol Exp Ther 340, 801-809. 
 
  
Steiner et al. 
 
23 
 
Legends to figures 
Figure 1. WT, HET and KO mice developed cocaine induced sensitization. (A) Time course of cocaine-
induced hyperlocomotion after the first cocaine administration (Day 2) in WT (square), HET (circle) 
and KO (triangle) males. Data represent the mean distance traveled (± SEM) in cm for 60 min (+10 
min habituation) in 8-9 mice. (B) Locomotor activity was daily monitored after ip injection of cocaine 
(15 mg/kg, filled symbols) or saline (open symbols) in WT, HET and KO males. Data represent the 
mean distance traveled (± SEM) in cm for 1h in 8-9 mice. (C) Amplitude of the behavioral 
sensitization in WT, HET and KO males. Data represent the mean ratio (± SEM) defined as: (distance 
post injection minus distance prior injection)/(distance post injection plus distance prior injection). 
(D, E and F) are equivalent experiments to (A, B and C) performed in female mice. Tukey post hoc 
test: * p-value<0.05, ** p-value<0.01 and *** p-value<0.001 versus saline, # p-value<0.05, ## p-
value<0.01 versus WT and $ p-value versus HET. 
Figure 2. WT, HET and KO mice developed robust cocaine-induced conditioned place preference. 
Data represent mean time (± SEM) expressed in seconds spent in the drug paired compartment for 
WT, HET and KO animals (A, males and B, females) before (open boxes) and after (filled boxes) 
cocaine conditioning in 7-8 mice. (C, D) Data represent mean time (± SEM) expressed in seconds 
spent in the drug paired compartment for WT, HET and KO animals (E, males and F, females) before 
conditioning (open boxes) and after (filled boxes) a 2-week period of cocaine abstinence (passive 
extinction) in 7-8 mice. Tukey post hoc test: * p-value<0.05 and *** p-value<0.001 versus the 
respective pretest session, # p-value<0.05 versus WT. 
Figure 3. KO mice exhibited reduced conditioned responses to cocaine cues. (A) Data represent mean 
cocaine intake (± SEM) expressed in mg/kg in WT (square) and Hcrt KO (triangle) male mice (n=7-8). 
Tukey post hoc test: * p-value<0.05, *** p-value<0.001 versus the 0.5 mg/kg dose in respective 
genotype and # p-value<0.05 versus the 1.5 mg/kg dose in WT mice. (B) Data represent mean (± 
SEM) number of nosepokes during cocaine acquisition (average of last three session), extinction and 
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cue-induced reinstatement phases in WT (filled boxes) and KO (open boxes) male (n=7-8).  Tukey 
post hoc test: *** p-value<0.001 versus the respective acquisition session, ## p-value<0.01 versus 
WT males and $$$ p-value<0.001 versus the respective extinction session. (C) Data represent mean 
(± SEM) number of nosepokes during cocaine acquisition (average of last three session) and during 1-
28 days of withdrawal after last cocaine self-administration in WT (filled boxes, n=9) and KO (open 
boxes, n=12) animals. Tukey post hoc test: * p-value<0.05, ** p-value<0.01 and *** p-value<0.001 
versus the respective acquisition session (cocaine 1 mg/kg), # p-value<0.05 and ## p-value<0.01 
versus WT males and $$$ p-value<0.001 versus the respective extinction session.  
Figure 4. KO mice failed to reinstate a previously extinguished saccharine seeking behavior following 
presentation of reward cues, but performed normally a visual discrimination task. Data represent 
mean number of nosepokes (± SEM) following presentation of reward cues (A) and mean number of 
correct, incorrect, premature and perseverative nosepokes (± SEM) (B) in WT (black boxes, n=8-10) 
and Hcrt KO (white boxes, n=6-9) mice. Tukey post hoc tests: *** p-value<0.001 versus respective 
acquisition session, ### p<0.01 versus WT acquisition session, $$ p-value<0.01 versus WT extinction 
session. 
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Results 
Behavioral sensitization in the running wheels 
WT, HET and KO females were tested in running wheels, for 60 min after saline treatment, twice on 
day 1. From day 2 to day 7, mice were monitored first for 60 min after a saline injection, and second 
for 60 min following a 15 mg/kg ip cocaine administration. On day 1 (saline treatment, Suppl. Figure 
1A), a two-way repeated measure ANOVA revealed significant main effects for genotype (F(2,30)=3.45, 
p<0.05), with KO females displaying a reduced activity. Saline treatment did not modify locomotor 
activity compared to the pre-injection test (F(1,30)=0.084, p>0.05) and the interaction was not 
significant as well (F(2,30)=0.181, p>0.05). Post-hoc tests revealed that KO females treated with saline 
exhibited similar locomotor activity compared to both WT and HET mice treated with saline (Tukey 
HSD, p=0.085 and p=0.055, respectively). On the second day (first cocaine exposure, Suppl. Figure 
1B), all mice exhibited similar locomotion after cocaine injection (F(2,30)=2.860, p=0.073) and on the 
seventh day (sixth cocaine administration, Suppl. Figure 1C), all mice exhibited similar performances, 
with no significant effect for genotype (F(2,30)=2.558, p=0.094) and no effect for cocaine treatment 
(F(1,30)=3.303, p=0.079). 
Increased locomotor activity during the posttest session of the conditioned place preference 
We monitored the distance travelled by mice during the 20 min of the pretest (before cocaine 
conditioning) and the posttest (after cocaine conditioning) sessions. Although mice did not receive 
any cocaine administration on the posttest session, we report an increased locomotor activity after 
cocaine conditioning [F(1,186)(treatment x session)=37.3, p<0.001] in WT animals [males: 4284 ± 208 
cm (after cocaine conditioning) vs 3244 ± 157 cm (before cocaine conditioning); females: 4650 ± 134 
cm (after) vs 3616 ± 336 cm (before), p<0.05 Tukey’s HSD post-hoc tests]. Similarly, we report an 
increased locomotor activity in HET mice [males: 4248 ± 191 cm (after) vs 2813 ± 128 cm (before); 
females: 4555 ± 205 cm (after) vs 3450 ± 269 cm (before), p<0.05 Tukey’s HSD post-hoc tests]. 
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However, KO animals did not exhibit any increased locomotor activity after cocaine conditioning 
[males: 3203 ± 173 (after) vs 2876 ± 170 cm (before); females: 3799 ± 169 cm (after) vs 2869 ± 370 
cm (before), p>0.05 Tukey’s HSD post-hoc tests]. 
Saccharine seeking in males 
WT and KO males were tested in a progressive ratio schedule of reinforcement for saccharine 0.2% 
during the light (quiet) and the dark (active) phases of their circadian cycle, once under food 
restriction and once sated (Suppl. Figure 4). A two-way repeated measure ANOVA revealed 
significant main effects for genotype (F(1,80)=12.923, p<0.001), food condition (F(1,80)=25.679, p<0.001) 
and a significant genotype x food condition interaction (F(1,30)=4.072, p<0.05) proving that KO mice 
exhibited a reduced motivation for saccharine seeking under food restriction compared to WT 
animals.  
When looking at WT mice behavior only, a two-way repeated measure ANOVA revealed significant 
main effects of food condition (F(1,40)=29.640, p<0.001), but no effect of the cycle (F(1,40)=1.527, 
p>0.05). Tukey’s HSD post hoc tests revealed a significant reduction of saccharine seeking in sated 
WT mice (either during the light or the dark period). 
When looking at KO mice behavior, a two-way repeated measure ANOVA failed to reveal any 
significant effects of food condition (F(1,40)=4.032, p=0.0514), or cycle (F(1,40)=0.153, p>0.05).  
Cocaine incubation craving 
Cocaine incubation craving is usually interpreted by comparing the first and last day of abstinence. 
Here, we compared nose poke responses during abstinence to nose poke responses during cocaine 
intake. We considered important to stress out that both WT and KO mice exhibited similar cocaine 
intake, and similar seeking behaviors on d1 and d7, and found intriguing that nose poking started 
decreasing on d14 in KO mice, while we observed the absence of place preference after a 2-week 
period of passive extinction. These observations suggest that cocaine maintains its reinforcing 
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properties in KO mice, acutely and shortly after abstinence, but not after a prolonged abstinence. 
Since incubation craving typically compares a delayed session to d1 of abstinence, we compared d1 
and d21 in WT and KO mice. A two-way repeated measure ANOVA revealed a significant genotype x 
session interaction (F(1,19)=4.997, p<0.05), supporting a reduced incubation craving in Hcrt KO mice. 
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Legends to supplementary figures 
Suppl. figure 1. Locomotor sensitization of WT, HET and KO female mice assessed in running wheels. 
Data represent the mean distance traveled (± SEM) in cm for 60 min in 5-7 mice per group, (A) before 
and after saline injection, (B) before and after the first cocaine injection (15 mg/kg) and (C) before and 
after the last cocaine injection following chronic intermittent treatment with cocaine (15 mg/kg) in WT 
(square), HET (circle) and KO (triangle) mice. Tukey post hoc tests: * p-value<0.05 compared to WT 
mice; ns, non-significant compared to WT mice. 
Suppl. figure 2. WT, HET and KO mice developed robust cocaine-induced conditioned place preference. 
Data represent mean distance (± SEM) expressed in cm traveled by WT, HET and KO mice (A, males 
and B, females) before (open boxes) and after (filled boxes) cocaine conditioning in 7-8 mice. (C, D) 
Data represent mean distance (± SEM) expressed in cm traveled by WT, HET and KO mice (C, males 
and D, females) before conditioning (open boxes) and after (filled boxes) a 2-week period of cocaine 
abstinence (passive extinction) in 7-8 mice. 
Suppl. figure 3. WT and KO mice exhibited similar pattern of cocaine intake (0.7 mg/kg/infusion). (A) 
Data represent mean cocaine intake (± SEM) expressed in mg/kg in WT (square) and Hcrt KO (triangle) 
male mice (n=7-8) using a fixed ratio 1 time out 20 sec schedule. (B) Data represent mean number of 
cumulated lever presses (± SEM) and equivalent earned rewards using a progressive ratio schedule of 
reinforcement (n=6-7). 
Suppl. figure 4. Food restricted KO mice displayed reduced motivation for saccharine in a progressive 
ratio schedule of reinforcement. Data represent mean number of collected rewards (± SEM) during the 
dark (A) and the light (B) phase in WT (black boxes) and KO (white boxes) mice. Tukey post hoc tests: 
* p-value<0.05, ** p-value<0.01, *** p-value<0.001 versus food restricted WT (satiety effect) and # p-
value<0.05 versus food restricted WT mice (genotype effect).  
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Steiner et al., Supplementary Figure 1 
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Steiner et al., Supplementary Figure 2 
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Steiner et al., Supplementary Figure 3 
 
 
 
 
 
  
Steiner et al. 
 
9 
 
Steiner et al., Supplementary Figure 4 
 
 
 
 
 
 
